Recombinant CDV compositions and uses thereof
AssigneeMerial Limited
InventorsJean-Christophe Audonnet, Jules Minke
Life of this patent
Estimating the term…
Abstract
The present invention provides vectors that contain and express in vivo or in vitro CDV polypeptides or antigens that elicit an immune response in animal against CDV, compositions comprising said vectors and/or CDV polypeptides, and methods of vaccination against CDV. The invention further provides methods for inducing an immunogenic or protective response against CDV and other canine virus, as well as methods for preventing or treating CDV and other canine virus or disease state(s) caused by CDV and other canine virus.
Claims15
A composition comprising a canarypox vector ALVAC, wherein the ALVAC vector is vCP2392 comprising the polynucleotide of SEQ ID NO:
- 14.
A canarypox vector ALVAC, wherein the ALVAC vector is vCP2392 comprising the polynucleotide of SEQ ID NO:
- 14.
Dependencies are inferred from the claim text.